|
Novartis Cannibalizes Gleevec to Boost New Cancer Drug
Novartis AG wants patients to stop taking one of its best-selling drugs. The Swiss company revolutionized leukemia treatment with Gleevec, a drug that turned a deadly blood cancer into a chronic disease more than a decade ago.
Businessweek |
Register Now
Archives